
Click to view full size
JEFFERSON CITY, Mo. (AP) — Agrochemical maker Bayer will pay up to US$7.25 billion over two decades to resolve thousands of claims from American cancer patients asserting that the company should have warned people that its popular weed killer Roundup could cause lymphoma, according to a settlement approved Friday by a Missouri judge.
The nationwide settlement applies to Roundup users who are already ill and those who are diagnosed with non-Hodgkin lymphoma in future years.
Participants could get an average of between $10,000 and $165,000, depending on how they used the product, how old they were when diagnosed and the severity of their illness.
Continues on Jamaica Gleaner
The portable companion to gazettE. Get notifications, track read articles, and more. The latest news from Trinidad and Tobago, in one place.
Related stories
See articles related to "US court approves $7.25 billion settlement with Bayer over claims Roundup weed killer caused cancer"